Skip to content
★ Sign in to follow
SS

Staffan Strömberg

Infant Bacterial Therapeutics ABInfant Bacterial Therapeutics
Total declarations
13
Companies
2
▲ Purchases (7 ops.)
€292k
▼ Sales (3 ops.)
€822k

Latest filing published 10 Sept 2026 for INFANT BACTERIAL THERAPEUTICS AB.

Filing timeline

BuySale
Staffan Strömberg

Insider track record

Disclosed buys
7
Disclosed sells
3
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Staffan Strömberg: trading record in brief

This profile gathers the share dealings of Staffan Strömberg across 2 companies, led by Infant Bacterial Therapeutics and Infant Bacterial Therapeutics AB. We count 13 filings; the first trade dates from 10 May 2017 and the latest from 10 September 2026.

In open-market terms, that means 7 purchases worth €292k on one side and 3 sales worth €822k on the other. On balance, insiders were net sellers of €530k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.

Half of the purchases are above €32k and half below.

The latest filing, published on 10 September 2026, reports a share grant in Infant Bacterial Therapeutics AB. The latest purchase dates back some time: it was published 891 days ago, on 31 May 2024. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Staffan Strömberg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations